Metabolic & Lysosomal
Also called PKU
Phenylketonuria (PKU) is an inherited metabolic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which normally converts the amino acid phenylalanine into tyrosine. Without this enzyme, phenylalanine accumulates to toxic levels in the blood and cerebrospinal fluid, causing intellectual disability, behavioral problems, and neurological complications if left untreated.
About trials for Phenylketonuria
Clinical trials for PKU are exploring enzyme replacement therapies, gene therapies, and new drugs like pegvaliase (Palynziq) that can help reduce dietary restrictions. The National Institutes of Health and PKU patient registries maintain current trial information.
Try Match Me →Typically identified in newborns through screening; affects males and females equally. More common in individuals of Scandinavian, Celtic, and Eastern European descent.
Clinical trials for PKU are exploring enzyme replacement therapies, gene therapies, and new drugs like pegvaliase (Palynziq) that can help reduce dietary restrictions. The National Institutes of Health and PKU patient registries maintain current trial information. The National Organization for Rare Disorders (NORD) and the PKU Foundation are excellent resources for finding trials and connecting with other families managing the condition. Your metabolic specialist can help determine trial eligibility and discuss whether participation might reduce the need for strict dietary management.
Wilson disease is a rare inherited disorder where the body accumulates toxic levels of copper, primarily in the liver, b...
Fabry disease is a rare inherited lysosomal storage disorder where a missing enzyme causes fatty substances called globo...
Pompe disease is a rare inherited lysosomal storage disorder caused by deficiency of the enzyme acid alpha-glucosidase, ...